Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-IgAN: Immunosuppression in IgA Nephropathy
NCT00554502Phase 3Completed
- Sponsor
- RWTH Aachen University
- Start
- Feb 2008
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone, prednisolone, cyclophosphamide, azathioprine in IgA nephropathy (IgAN), sponsored by RWTH Aachen University. Started Feb 2008; status: completed.
02
Drugs
methylprednisoloneprednisolonecyclophosphamideazathioprine
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT00554502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00554502.